Flexeril (cyclobenzaprine) does not show up on standard workplace drug tests, but it can trigger a false positive for tricyclic antidepressants (TCAs). This is the main concern for anyone taking the muscle relaxant before a screening. Standard 5-panel and 10-panel drug tests don’t look for muscle relaxants at all, so Flexeril itself won’t be flagged. The problem is what it can be mistaken for.
Why Flexeril Triggers a False Positive for Antidepressants
Cyclobenzaprine, the active ingredient in Flexeril, is structurally almost identical to amitriptyline, a tricyclic antidepressant. The two molecules are so similar that older laboratory methods can barely tell them apart. Chromatographic assays, one of the techniques used to identify substances in urine, show retention time differences of only seconds between cyclobenzaprine and individual tricyclic antidepressants. Their chemical “fingerprints” also produce nearly identical color stains during testing.
Because of this resemblance, immunoassay-based drug screens (the quick, initial tests most labs use) can’t reliably distinguish Flexeril from an actual TCA. If a screening panel includes a TCA category, taking Flexeril may cause it to light up as positive for tricyclic antidepressants, even though you’ve never taken one.
What Standard Drug Tests Actually Screen For
A typical 5-panel drug test, the kind used for most pre-employment and workplace screenings, checks for five categories: marijuana, cocaine, amphetamines, opiates, and PCP. A 10-panel test adds benzodiazepines, barbiturates, methadone, propoxyphene, and methaqualone. Neither panel specifically targets muscle relaxants like cyclobenzaprine.
Some expanded panels or hospital toxicology screens do include a TCA category. These are more common in emergency departments and pain management clinics than in routine employment testing. If your screening includes a TCA line, that’s where the false positive risk comes into play. A standard workplace drug test without a TCA category won’t flag Flexeril at all.
How Long Flexeril Stays in Your System
Cyclobenzaprine is processed slowly by the liver and cleared through the kidneys. According to the FDA’s prescribing information, the drug has an average half-life of 18 hours, with a wide range of 8 to 37 hours depending on the individual. A half-life is the time it takes for half the drug to leave your body.
As a general rule, it takes about five half-lives for a substance to be effectively eliminated. For most people, that means cyclobenzaprine clears the body in roughly 4 to 8 days after the last dose. People who metabolize the drug more slowly, including older adults and those with liver conditions, may retain it longer. If you’ve been taking Flexeril daily for weeks, the buildup means it could take closer to the upper end of that range to fully clear.
What Happens If You Get a False Positive
A positive initial screen is not a final result. When an immunoassay flags a sample as positive for TCAs, the standard protocol is to send it for confirmatory testing. This second round uses more precise methods, typically gas chromatography-mass spectrometry, which can distinguish cyclobenzaprine from actual tricyclic antidepressants. A confirmatory test will correctly identify the substance as cyclobenzaprine rather than a TCA.
For federally regulated testing, such as Department of Transportation screenings, a Medical Review Officer (MRO) reviews any positive result before it’s reported to the employer. The MRO contacts you to ask about prescriptions and may call your pharmacy or prescribing physician to verify that you have a legitimate prescription. Simply showing a photo of your medication label isn’t enough. The MRO will independently confirm the prescription through the pharmacy.
If you have a valid prescription for Flexeril and the confirmatory test identifies cyclobenzaprine (not a TCA), the result is typically reported as negative. The key is that confirmatory testing can tell the difference, even when the initial screen cannot.
How to Prepare If You’re Taking Flexeril
If you know a drug test is coming, the simplest step is to bring documentation of your prescription. Have your pharmacy name, prescriber’s name, and prescription number available. You don’t need to disclose your medication to the person administering the test, but be ready to share it with the MRO if a false positive occurs.
Stopping Flexeril before a test is a decision to make with your prescriber, not on your own. Abruptly discontinuing the medication may not help much anyway if it’s within the detection window, and it could cause a return of the muscle spasms or pain you’re treating. The confirmatory testing process exists specifically to sort out situations like this, so a valid prescription and an accurate second test will resolve the issue in most cases.
If you’re concerned about a non-federally regulated test (a private employer screening, for example), it’s worth asking the testing facility whether their panel includes a TCA category and whether they automatically run confirmatory testing on positives. Not all private employers follow the same verification procedures that federal testing requires, so knowing the process ahead of time gives you the chance to advocate for confirmatory testing if needed.